Robert Bednarek
Dermatology · Fort Wayne, INNPI 1902291875
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $907 and has fallen 83.3% since, to $151 in 2025. That places this record below the midpoint for dermatology clinicians in IN, where the typical reported total is $3,818.
Across 116 payments — averaging $26.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$565
- AbbVie$483
- Sanofi$334
- Johnson & Johnson$270
- Regeneron Healthcare Solutions, Inc.$257
- Novartis$165
- plus $944 from 16 others
What the payments were for
- Food & beverage$2,97198%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 9 | $565 |
| AbbVie | 22 | $483 |
| Sanofi | 15 | $334 |
| Johnson & Johnson | 12 | $270 |
| Regeneron Healthcare Solutions, Inc. | 12 | $257 |
| Novartis | 9 | $165 |
| Merck | 3 | $143 |
| Smith+Nephew | 6 | $133 |
| VYNE Pharmaceuticals Inc. | 2 | $132 |
| Pfizer | 3 | $114 |
| Lilly USA, LLC | 6 | $111 |
| Organogenesis Inc. | 3 | $60 |
| Incyte Corporation | 2 | $51 |
| Genentech USA, Inc. | 2 | $51 |
| Convatec Inc. | 2 | $41 |
| Biofrontera Inc. | 2 | $20 |
| Triad Life Sciences Inc. | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Genentech, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,018 in reported general payments places this provider in the 45th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 285 | $3,690 |
| Mupirocin | 222 | $1,707 |
| Minocycline Hcl | 27 | $286 |
| Cephalexin | 50 | $258 |
| Tramadol Hcl | 53 | $108 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Wayne
- Jeffrey SassmannshausenFort Wayne$489K
- Rohit KakarFort Wayne$40K
- Jennifer HobbsFort Wayne$16K
- Edward SarkisianFort Wayne$14K
- Patrick VeerkampFort Wayne$12K
- Dara SpearmanFort Wayne$9K
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.